40 related articles for article (PubMed ID: 22753738)
1. Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner.
Tilsed CM; Morales MLO; Zemek RM; Gordon BA; Piggott MJ; Nowak AK; Fisher SA; Lake RA; Lesterhuis WJ
BMC Cancer; 2024 Feb; 24(1):203. PubMed ID: 38350880
[TBL] [Abstract][Full Text] [Related]
2. CHEK2 signaling is the key regulator of oocyte survival after chemotherapy.
Emori C; Boucher Z; Bolcun-Filas E
Sci Adv; 2023 Oct; 9(42):eadg0898. PubMed ID: 37862420
[TBL] [Abstract][Full Text] [Related]
3. A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements.
Kimmerling RJ; Stevens MM; Olcum S; Minnah A; Vacha M; LaBella R; Ferri M; Wasserman SC; Fujii J; Shaheen Z; Sundaresan S; Ribadeneyra D; Jayabalan DS; Agte S; Aleman A; Criscitiello JA; Niesvizky R; Luskin MR; Parekh S; Rosenbaum CA; Tamrazi A; Reid CA
Commun Biol; 2022 Nov; 5(1):1295. PubMed ID: 36435843
[TBL] [Abstract][Full Text] [Related]
4. STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway.
Cheradame L; Guerrera IC; Gaston J; Schmitt A; Jung V; Goudin N; Pouillard M; Radosevic-Robin N; Modesti M; Judde JG; Cairo S; Goffin V
Oncogene; 2021 Dec; 40(49):6627-6640. PubMed ID: 34625708
[TBL] [Abstract][Full Text] [Related]
5. An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.
Lin YH; Satani N; Hammoudi N; Yan VC; Barekatain Y; Khadka S; Ackroyd JJ; Georgiou DK; Pham CD; Arthur K; Maxwell D; Peng Z; Leonard PG; Czako B; Pisaneschi F; Mandal P; Sun Y; Zielinski R; Pando SC; Wang X; Tran T; Xu Q; Wu Q; Jiang Y; Kang Z; Asara JM; Priebe W; Bornmann W; Marszalek JR; DePinho RA; Muller FL
Nat Metab; 2020 Dec; 2(12):1413-1426. PubMed ID: 33230295
[TBL] [Abstract][Full Text] [Related]
6. Improving the Brain Delivery of Chemotherapeutic Drugs in Childhood Brain Tumors.
Triarico S; Maurizi P; Mastrangelo S; Attinà G; Capozza MA; Ruggiero A
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31200562
[TBL] [Abstract][Full Text] [Related]
7. Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in
Bidadi B; Liu D; Kalari KR; Rubner M; Hein A; Beckmann MW; Rack B; Janni W; Fasching PA; Weinshilboum RM; Wang L
Front Pharmacol; 2018; 9():158. PubMed ID: 29593529
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro antileukemic activity of obatoclax and ABT-737.
Opydo-Chanek M; Mazur L
Tumour Biol; 2016 Aug; 37(8):10839-49. PubMed ID: 26880588
[TBL] [Abstract][Full Text] [Related]
9. Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (PBTC-001).
Blaney SM; Boyett J; Friedman H; Gajjar A; Geyer R; Horowtiz M; Hunt D; Kieran M; Kun L; Packer R; Phillips P; Pollack IF; Prados M; Heideman R
J Clin Oncol; 2005 Jan; 23(3):525-31. PubMed ID: 15659498
[TBL] [Abstract][Full Text] [Related]
10. Mafosfamide as a new anticancer agent: preclinical investigations and clinical trials.
Mazur L; Opydo-Chanek M; Stojak M; Wojcieszek K
Anticancer Res; 2012 Jul; 32(7):2783-9. PubMed ID: 22753738
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.
Blaney SM; Balis FM; Berg S; Arndt CA; Heideman R; Geyer JR; Packer R; Adamson PC; Jaeckle K; Klenke R; Aikin A; Murphy R; McCully C; Poplack DG
J Clin Oncol; 2005 Mar; 23(7):1555-63. PubMed ID: 15735131
[TBL] [Abstract][Full Text] [Related]
12. Oxazaphosphorine effects in L 5222 rat leukemia.
Pohl J; Reissmann T; Voegeli R
Methods Find Exp Clin Pharmacol; 1987 Sep; 9(9):589-94. PubMed ID: 3437788
[TBL] [Abstract][Full Text] [Related]
13. Glufosfamide as a new oxazaphosphorine anticancer agent.
Mazur L; Opydo-Chanek M; Stojak M
Anticancer Drugs; 2011 Jul; 22(6):488-93. PubMed ID: 21427562
[TBL] [Abstract][Full Text] [Related]
14. Trofosfamide in the palliative treatment of cancer: a review of the literature.
Latz D; Nassar N; Frank R
Onkologie; 2004 Dec; 27(6):572-6. PubMed ID: 15591719
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
